These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 16791582

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A double-peak phenomenon in the pharmacokinetics of alprazolam after oral administration.
    Wang Y, Roy A, Sun L, Lau CE.
    Drug Metab Dispos; 1999 Aug; 27(8):855-9. PubMed ID: 10421610
    [Abstract] [Full Text] [Related]

  • 26. Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam.
    Furukori H, Otani K, Yasui N, Kondo T, Kaneko S, Shimoyama R, Ohkubo T, Nagasaki T, Sugawara K.
    Neuropsychopharmacology; 1998 May; 18(5):364-9. PubMed ID: 9536449
    [Abstract] [Full Text] [Related]

  • 27. Effect of alosetron on the pharmacokinetics of alprazolam.
    D'Souza DL, Levasseur LM, Nezamis J, Robbins DK, Simms L, Koch KM.
    J Clin Pharmacol; 2001 Apr; 41(4):452-4. PubMed ID: 11304902
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation.
    Molanaei H, Stenvinkel P, Qureshi AR, Carrero JJ, Heimbürger O, Lindholm B, Diczfalusy U, Odar-Cederlöf I, Bertilsson L.
    Eur J Clin Pharmacol; 2012 May; 68(5):571-7. PubMed ID: 22159869
    [Abstract] [Full Text] [Related]

  • 34. Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.
    Saletu B, Grünberger J, Linzmayer L, Semlitsch HV, Anderer P, Chwatal K.
    Br J Clin Pharmacol; 1994 Feb; 37(2):145-56. PubMed ID: 7910470
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers.
    Donovan JL, DeVane CL, Chavin KD, Taylor RM, Markowitz JS.
    Drug Metab Dispos; 2003 May; 31(5):519-22. PubMed ID: 12695337
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics and psychomotor performance of alprazolam: concentration-effect relationship.
    Wright CE, Sisson TL, Fleishaker JC, Antal EJ.
    J Clin Pharmacol; 1997 Apr; 37(4):321-9. PubMed ID: 9115058
    [Abstract] [Full Text] [Related]

  • 39. The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions.
    Haddad A, Davis M, Lagman R.
    Support Care Cancer; 2007 Mar; 15(3):251-7. PubMed ID: 17139496
    [Abstract] [Full Text] [Related]

  • 40. Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolam.
    van Waterschoot RA, Rooswinkel RW, Sparidans RW, van Herwaarden AE, Beijnen JH, Schinkel AH.
    Drug Metab Dispos; 2009 Dec; 37(12):2305-13. PubMed ID: 19752211
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.